Together with adopting a healthy lifestyle, Medicines are important pillar in
keeping healthy or getting our health back if we may have been ill. However, we
often know very little about the medicines we use. This section is a guide to the
numerous medicines that are registered in Kenya.
We appreciate your feedback! [Last updated Dec:2011]
Displaying 2531-2540 of 12466 results.
Product Name | Dosage Form | Active Ingredients | Manufacturer Name | Class | |
---|---|---|---|---|---|
ALBICAN ? V ? CREAM | CREAM | Clotrimazole USP 1% w/w | CIPLA LTD; INDIA | ANTI-FUNGALS | Report Effects |
SIMPLY ONE 160 INHALER | INHALER | CICLESONIDE 160 MCG; FORMOTEROL FUMARATE 2H2O PH. EUR. 4.5 MCG PER ACTUATION | CIPLA LTD; INDIA | RESPIRATORY TRACT DRUGS | Report Effects |
PHOTERICIN B INJECTION | INJECTION | Amphotericin USP 50 mg/vial | CIPLA LTD; INDIA | ANTINEOPLASTICS & IMMUNOSUPPRESSIVE DRUGS | Report Effects |
SIMPLY ONE 160 INHALER | INHALER | CICLESONIDE 160 MCG; FORMOTEROL FUMARATE 2H2O PH. EUR. 4.5 MCG PER ACTUATION | CIPLA LTD; INDIA | RESPIRATORY TRACT DRUGS | Report Effects |
BLEOCIP INJECTION | INJECTION | Bleomycin Sulphate USP equivalent to Bleomycin 15 Units/vial | CIPLA LTD; INDIA | ANTINEOPLASTICS & IMMUNOSUPPRESSIVE DRUGS | Report Effects |
METASPRAY NASAL SPRAY | NASAL SPRAY | Mometasone Furoate Monohydrate equivalent to Mometasone Furoate USP 50mcg | CIPLA LTD; INDIA | OPHTALMOLOGICAL E.N.T. PREPARATIONS | Report Effects |
CEFASYN ? 500 TABLETS | TABLETS | CEFUROXINE AXETIL USP CEFUROXIME 500 MG | CIPLA LTD; INDIA | ANTI-BIOTICS | Report Effects |
METASPRAY NASAL SPRAY | NASAL SPRAY | MOMETASONE FUROATE MONOHYDRATE EQUIVALENT TO MOMETASONE FUROATE USP 50MCG | CIPLA LTD; INDIA | OPHTALMOLOGICAL E.N.T. PREPARATIONS | Report Effects |
CEFASYN ? 500 TABLETS | TABLETS | CEFUROXINE AXETIL USP CEFUROXIME 500 MG | CIPLA LTD; INDIA | ANTI-BIOTICS | Report Effects |
MOXICIP 400MG/100ML INFUSION | INJECTION | Moxifloxacin Hydrochloride equivalent to Moxifloxacin 400mg, Mannitol IP 5%w/v | CIPLA LTD; INDIA | ANTI-BIOTICS | Report Effects |